- Home
- ELAB
ELAB
Elevai Labs Inc.
as 07-26-2024 4:00pm EST
Stocks
Elevai Labs Inc is a California-based physician-dispensed skincare company with a focus on modernizing aesthetic skincare. It has commercialized ELEVAI Exosomes a next-generation, patent-pending technology used in its ELEVAI flagship products.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEWPORT BEACH |
| Market Cap: | 11.0M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 70.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.43 - $4.24 | Next Earning Date: | 08-27-2024 |
| Revenue: | $2,184,338 | Revenue Growth: | 147.01% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Elevai Labs Inc. News
ELAB Breaking Stock News: Dive into ELAB Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
GlobeNewswire
a month ago
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
GlobeNewswire
a month ago
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
Motley Fool
2 months ago
Better AI Stock: Palantir vs. Snowflake
Motley Fool
2 months ago
Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?
Motley Fool
2 months ago
BigBear.ai Stock: Buy, Sell, or Hold?
AFP
2 months ago
Indonesia's first Olympic gymnast encourages others to 'dream higher'
Motley Fool
2 months ago
Where Will CrowdStrike Stock Be in 1 Year?
Compare ELAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELAB Elevai Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.